Literature DB >> 87724

Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics.

J C Pickup, H Keen, J A Parsons, K G Alberti, A S Rowe.   

Abstract

Blood-levels of glucose and the major intermediary metabolites, lactate, pyruvate, 3-hydroxybutyrate, and alanine, were measured in 7 insulin-dependent diabetics during 24 h of continuous subcutaneous insulin infusion (C.S.I.I.) from a portable dual-rate syringe pump. Results were compared with metabolic profiles during the patients' conventional insulin treatment and with those of 17 non-diabetics. The mean 24 h plasma-glucose during C.S.I.I. was not significantly different from that in non-diabetics. During infusion blood concentrations of lactate, pyruvate, 3-hydroxybutyrate, and alanine were also close to those in the non-diabetic state. Thus, C.S.I.I. provides strict control not only of blood-glucose but also of major metabolites, an essential prerequisite for investigating the influence of good metabolic control on diabetic microangiography.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 87724     DOI: 10.1016/s0140-6736(79)92225-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  31 in total

1.  'Do-it-yourself' insulin pump. Case report.

Authors:  D Bruttomesso; G Lisato; S Del Prato; A Tiengo
Journal:  Acta Diabetol Lat       Date:  1989 Jan-Mar

2.  Continuous subcutaneous insulin infusion: a long-term study.

Authors:  A Lombardo; S Scavino; G Scornavacca; G Oliva; C Sipione; R Cacciola; L Motta
Journal:  Acta Diabetol Lat       Date:  1986 Jan-Mar

3.  The value of good control.

Authors:  J C Pickup; H Keen
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

4.  The metabolic and hormonal effects of continuous subcutaneous insulin infusion therapy in diabetic children.

Authors:  G Soltész; D Molnár; T Decsi; A Hamar; L Klujber
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

5.  Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.

Authors:  M A Berk; W E Clutter; D Skor; S D Shah; R P Gingerich; C A Parvin; P E Cryer
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

6.  Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion.

Authors:  J C Pickup; G C Viberti; R W Bilous; H Keen; K G Alberti; P D Home; C Binder
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

7.  The effect of continuous subcutaneous insulin infusion and conventional insulin regimes on 24-hour variations of blood glucose and intermediary metabolites in the third trimester of diabetic pregnancy.

Authors:  J M Potter; J P Reckless; D R Cullen
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

8.  Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion.

Authors:  I Lager; P Lönnroth; H von Schenck; U Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03

9.  Improvement of glucose homeostasis in insulin-dependent diabetics using a miniature insulin infusion pump with a fixed profile.

Authors:  K Køolendorf; J Bojsen; B Løorup
Journal:  Diabetologia       Date:  1980       Impact factor: 10.122

10.  Unrecognised nocturnal hypoglycaemia masquerading as senile dementia.

Authors:  R Ramasamy
Journal:  Postgrad Med J       Date:  1983-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.